The Director Of Bausch Health Companies Inc. (BHC) Purchased 4,550,357 Shares

0
3

As of Wednesday close, Bausch Health Companies Inc.’s (NYSE:BHC) stock was down -$0.19, moving down -2.74 percent to $6.75. The average number of shares traded per day over the past five days has been 9,644,200 shares. 1 time new highs have been achieved over the past 5 days, with a -$0.22 fall in that time frame. In the last twenty days, the average volume was 5,388,685, while in the previous 50 days, it was 5,248,002.

Since last month, BHC stock retreated -2.46%. Shares of the company fell to $6.20 on 11/03/22, the lowest level in the past month. A 52-week high of $28.35 was reached on 01/05/22 after having rallying from a 52-week low of $4.00. Since the beginning of this year, BHC’s stock price has dropped by -75.55% or -$20.86, and marked a new high 3 times. However, the stock has declined by -76.19% since its 52-week high.


China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.

Sponsored


BHC stock investors should be aware that Bausch Health Companies Inc. (BHC) stock had its last reported insider trading activity 177 days ago on Jun 01. Bausch Health Companies Inc., the 10% Owner of the company, disposed of 4,550,357 shares for $17.05 on Jun 01. It resulted in a $77,606,339 divestment by the insider. Bausch Health Companies Inc. sold 35,000,000 shares at an average price of $17.05 on May 10. The insider now owns 315,000,000 shares following the transaction. On Apr 14, U.S. President-Pharma Business Spurr Robert sold 1,595 shares at $22.19 apiece. The transaction was valued at $35,393.

Valuation Metrics

Right now, Bausch Health Companies Inc. (BHC) has a P/E ratio of about 9.67. The stock’s beta is 0.95.

Financial Health

In the three months ended June 29, Bausch Health Companies Inc.’s quick ratio stood at 0.80, while its current ratio was 1.00, showing that the company is not able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 71.20% percent. In the year ended June 29, operating margins totaled 21.40%. Based on annual data, BHC earned $6.04 billion in gross profit and brought in $8.43 billion in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 2.10%. Return on equity (ROE) for the past 12 months was -66.00%.

In Bausch Health Companies Inc.’s quarter-end financial report for June 29, it reported total debt of $20.8 billion. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. BHC’s revenue fell -3.18% to $1.97 billion during the quarter, while net income inched up to $2.05 billion. While analysts expected Bausch Health Companies Inc. to report $1.23 quarterly earnings, the actual figure was $0.77 per share, beating the consensus estimate by -37.40%. During the quarter, the company generated $601.0 million in EBITDA. The liabilities of Bausch Health Companies Inc. were 25.86 billion at the end of its most recent quarter ended June 29, and its total debt was $21.81 billion. The value of shareholders’ equity is $361.87 million.

Technical Picture

This quick technical analysis looks at Bausch Health Companies Inc.’s (BHC) price momentum. With a historical volatility rate of 93.69%, the RSI 9-day stood at 43.60% on 23 November.

With respect to its five-day moving average, the current Bausch Health Companies Inc. price is down by -3.16% percent or -$0.22. At present, BHC shares trade -5.99% below its 20-day simple moving average and -25.41% percent below its 100-day simple moving average. However, the stock is currently trading approximately -14.01% below its SMA50 and -72.76% below its SMA200.

Stochastic coefficient K was 28.99% and Stochastic coefficient D was 43.92%, while ATR was 0.57. Given the Stochastic reading of 14.77% for the 14-day period, the RSI (14) reading has been calculated as 46.66%. As of today, the MACD Oscillator reading stands at -0.29, while the 14-day reading stands at -0.26.

Analyst Ratings

Bausch Health Companies Inc. downgraded its rating on Bausch Health Companies Inc. (NYSE: BHC) to a Hold in a note to investors on July 29, 2022. The analysts firm previously had a Buy rating on the stock.Bausch Health Companies Inc. (BHC) has been rated Hold by analysts. According to 0 brokerage firms, BHC is a sell, and 7 firms recommend it is a Hold. There are 1 analyst who say the stock is underweight. A total of 0 analysts rate Bausch Health Companies Inc. stock as buy, with 2 recommending it as overweight.

With a median target price of $8.00, the current consensus forecast for the stock is $6.00 – $35.00. Based on these forecasts, analysts predict Bausch Health Companies Inc. (BHC) will achieve an average price target of $12.00.

LEAVE A REPLY

Please enter your comment!
Please enter your name here